• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)
	Q2-CY2026	Q1-CY2026	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014
Balance Sheet Date			2025-Dec-31	2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30	2024-Mar-31	2023-Dec-31								2021-Dec-31	2021-Sep-30	2021-Jun-30	2021-Mar-31	2020-Dec-31	2020-Sep-30	2020-Jun-30	2020-Mar-31	2019-Dec-31	2019-Sep-30	2019-Jun-30	2019-Mar-31	2018-Dec-31	2018-Sep-30
Fiscal Period			Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024	Q3-FY2024	Q2-FY2024	Q1-FY2024	Q4-FY2023								Q4-FY2021	Q3-FY2021	Q2-FY2021	Q1-FY2021	Q4-FY2020	Q3-FY2020	Q2-FY2020	Q1-FY2020	Q4-FY2019	Q3-FY2019	Q2-FY2019	Q1-FY2019	Q4-FY2018	Q3-FY2018
Total Revenue																											0$	5,962$	5,962$	5,850$	5,735$	5,512$	5,062$
QoQ%																											(100.00%)	.00%	1.92%	2.01%	4.05%	8.89%
YoY%																											(100.00%)	8.16%	17.78%
Cost Of Revenue																											0$	4,240$	5,015$	4,160$	4,080$	3,920$	3,645$
Gross Profit																											0$	1,722$	947$	1,690$	1,655$	1,592$	1,417$
Gross Margin																												28.88%	15.88%	28.89%	28.86%	28.88%	27.99%
Operating Expenses			117,798$	115,915$	122,781$	133,457$	123,160$	122,024$	114,440$	130,813$	114,410$	113,607$	113,931$	130,005$					120,701$	113,860$	122,315$	145,079$	122,565$	117,922$	126,710$	158,041,358$	20,170$	8,056$	8,129$	14,542$	10,249$	8,235$	28,946$	23,974$	25,918$	2,201$
Operating Income				(115,915$)	(122,781$)	(133,457$)		(122,024$)	(114,440$)																		(20,170$)	(6,334$)	(7,182$)	(12,852$)	(8,594$)	(6,643$)	(27,529$)	(23,974$)	(24,663$)	(2,201$)
Operating Margin																												(106.24%)	(120.46%)	(219.69%)	(149.85%)	(120.52%)	(543.84%)
Interest Income
Interest Expenses
Income Before Tax			(118,605$)	(115,915$)	(122,781$)	(934,650$)	(123,160$)	(122,024$)	(114,440$)	(130,813$)	(114,410$)	(113,607$)	(113,931$)	(130,005$)					(120,701$)	(113,860$)	(122,315$)	(145,079$)	(122,565$)	(117,922$)	(126,710$)	(158,041,358$)	(20,170$)	(6,334$)	(7,182$)	(12,852$)	(8,594$)	(6,643$)	(28,527$)	(23,974$)	(24,663$)	(2,201$)
Tax Expenses
Net Income			(118,605$)	(115,915$)	(122,781$)	(934,650$)	(123,160$)	(122,024$)	(114,440$)	(130,813$)	(114,410$)	(113,607$)	(113,931$)	(130,005$)					(120,701$)	(113,860$)	(122,315$)	(145,079$)	(122,565$)	(117,922$)	(126,710$)	(158,041,358$)	(20,170$)	(6,334$)	(7,182$)	(12,852$)	(8,594$)	(6,643$)	(28,527$)	(23,974$)	(24,663$)	(2,201$)
Profit Margin																												(106.24%)	(120.46%)	(219.69%)	(149.85%)	(120.52%)	(563.55%)
TTM																											(261.83%)	(148.72%)	(152.96%)	(255.50%)
Earnings to Minority
Earnings to Common Shareholders			(118,605$)	(115,915$)	(122,781$)	(934,650$)	(123,160$)	(122,024$)	(114,440$)	(130,813$)	(114,410$)	(113,607$)	(113,931$)	(130,005$)					(120,701$)	(113,860$)	(122,315$)	(145,079$)	(122,565$)	(117,922$)	(126,710$)	(158,041,358$)	(20,170$)	(6,334$)	(7,182$)	(12,852$)	(8,594$)	(6,643$)	(28,527$)	(23,974$)	(24,663$)	(2,201$)
QoQ%			(2.32%)	5.59%	86.86%	(658.89%)	(.93%)	(6.63%)	12.52%	(14.34%)	(.71%)	.28%	12.36%						(6.01%)	6.91%	15.69%	(18.37%)	(3.94%)	6.94%	99.92%	(783,446.64%)	(218.44%)	11.81%	44.12%	(49.55%)	(29.37%)	76.71%	(18.99%)	2.79%	(1,020.54%)
YoY%			3.70%	5.01%	(7.29%)	(614.49%)	(7.65%)	(7.41%)	(.45%)	(.62%)									1.52%	3.45%	3.47%	99.91%	(507.66%)	(1,761.73%)	(1,664.27%)	(1,229,602.44%)	(134.70%)	4.65%	74.82%	46.39%	65.15%	(201.82%)
Earnings Per Share, Basic				0.00$		(0.03$)	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$					0.00$	0.00$	0.00$	0.00$	(0.01$)	(0.01$)	(0.01$)	(10.35$)	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$		0.00$
Earnings Per Share, Diluted			0.00$	0.00$	0.00$	(0.03$)	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$					0.00$	0.00$	0.00$	0.00$	(0.01$)	(0.01$)	(0.01$)	(10.35$)	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$		0.00$
Unlevered FCF Per Share, Basic				0.00$		0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$					0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$		0.00$	0.00$
Unlevered FCF Per Share, Diluted			0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$					0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$	0.00$		0.00$	0.00$
Average Shares, Basic				33,521,755		32,246,755	29,271,755	29,271,755	29,271,755	29,271,755	29,271,755	29,271,755	29,271,755	29,271,755					29,271,754	29,271,755	29,271,755	29,271,756	19,402,910	15,271,756	15,271,755	15,271,047	15,268,011	15,265,463	15,262,944	15,262,406	-167,853,495	76,302,299	76,296,225	76,295,171		76,134,028
Average Shares, Diluted			33,539,219	33,521,755	33,521,755	32,246,755	29,271,755	29,271,755	29,271,755	29,271,755	29,271,755	29,271,755	29,271,755	29,271,755					29,271,754	29,271,755	29,271,755	29,271,756	19,402,910	15,271,756	15,271,755	15,271,047	15,268,011	15,265,463	15,262,944	15,262,406	-167,853,495	76,302,299	76,296,225	76,295,171		76,134,028
EBIT			(118,605$)	(115,915$)	(122,781$)	(934,650$)	(123,160$)	(122,024$)	(114,440$)	(130,813$)	(114,410$)	(113,607$)	(113,931$)	(130,005$)					(120,701$)	(113,860$)	(122,315$)	(145,079$)	(122,565$)	(117,922$)	(126,710$)	(158,041,358$)	(20,170$)	(6,334$)	(7,182$)	(12,852$)	(8,594$)	(6,643$)	(28,527$)	(23,974$)	(24,663$)	(2,201$)
EBITDA			(118,605$)	(115,915$)	(122,781$)	(934,650$)	(123,160$)	(122,024$)	(114,440$)	(130,813$)	(114,410$)	(113,607$)	(113,931$)	(130,005$)					(120,701$)	(113,860$)	(122,315$)	(145,079$)	(122,565$)	(117,922$)	(126,710$)	(158,041,358$)	(20,170$)	(6,334$)	(7,182$)	(12,852$)	(8,594$)	(6,643$)	(28,527$)	(23,974$)	(24,663$)	(2,201$)

Copy Table ✓